Baillie Gifford

Baillie Gifford US Equity Growth

US Mega-cap Growth

Jun 2026 → Sep 2026

Our archive holds 4 letters from this strategy, behind 13 investment theses and positions in 21 companies. Every quote below is copied verbatim from the letter it came from.

4 letters in a year · follow all of Baillie Gifford for every strategy.

Performance

as of Sep 30, 2026 · net of fees · USD · US Growth Composite (net)

  • YTD
    −6.7%
    index +15.7%
  • 1Y
    −6.7%
    index +15.7%
  • 5Y · /yr
    −2.8%
    index +13.8%
  • 10Y · /yr
    +14.5%
    index +15.3%

Index: S&P 500 Index

Calendar years

  • 2025
    +31.7%
    index +17.6%
  • 2024
    +39.7%
    index +36.4%
  • 2023
    +17.5%
    index +21.6%
  • 2022
    −57.1%
    index −15.5%
Disclaimer

These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.

Read full disclosures →

What it bought and sold

  • New positionArmSep 2026
    During the quarter, we initiated positions in semiconductor companies Arm and KLA.
  • TrimmedModernaSep 2026
    Learning from the past, we halved the position.
  • AddedKLASep 2026
    During the quarter, we added to Arm and KLA, building our exposure to two high-quality businesses involved in the design and manufacture of leading-edge semiconductors.
  • New positionKLASep 2026
    During the quarter, we initiated positions in semiconductor companies Arm and KLA.
  • AddedArmSep 2026
    During the quarter, we added to Arm and KLA, building our exposure to two high-quality businesses involved in the design and manufacture of leading-edge semiconductors.
  • TrimmedTeslaJun 2026
    We funded this mostly by reducing Tesla, to manage exposure to Elon Musk companies, and kept the position at starter size, taking some profits after the stock surged in the days following IPO.
  • New positionIDEXX LaboratoriesJun 2026
    We have continued to broaden the portfolio's enduring growth exposure with new purchases in IDEXX and Mastercard.
  • New positionSpaceXJun 2026
    For most clients, we also initiated a small position in SpaceX at IPO, after holding the company privately in our UK closed-ended fund since 2018.
  • New positionMastercardJun 2026
    We have continued to broaden the portfolio's enduring growth exposure with new purchases in IDEXX and Mastercard.
  • AddedBroadcomJun 2026
    In April, we bought Broadcom.

Also held

Its investment theses

Every letter